SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,592.45 -318.56
( -0.39%)

Global Indices

Nasdaq

52,431.30 -76.19
(-0.15%)

Dow Jones

7,621.14 -19.24
(-0.25%)

Hang Seng

61,109.24 289.88
(0.48%)

Nikkei 225

10,906.25 43.16
(0.40%)

Forex

USD-INR

93.72 0.15
(0.16%)

EUR-INR

104.27 -0.51
(-0.49%)

GBP-INR

124.72 -0.66
(-0.52%)

JPY-INR

0.59 0.00
(-0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.604918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

41.23

79.22

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

Lyka Labs consolidated net profit rises 122.58% in the June 2026 quarter

Aug 10,2026

Net profit of Lyka Labs rose 122.58% to Rs 2.07 crore in the quarter ended June 2026 as against Rs 0.93 crore during the previous quarter ended June 2025. Sales rose 28.10% to Rs 42.31 crore in the quarter ended June 2026 as against Rs 33.03 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	42.31	33.03	28
OPM %	10.75	11.17	-
PBDT	3.96	3.46	14
PBT	1.95	1.35	44
NP	2.07	0.93	123

81,592.45 -318.56 ( -0.39%)

52,431.30 -76.19 (-0.15%)

7,621.14 -19.24 (-0.25%)

61,109.24 289.88 (0.48%)

10,906.25 43.16 (0.40%)

93.72 0.15 (0.16%)

104.27 -0.51 (-0.49%)

124.72 -0.66 (-0.52%)

0.59 0.00 (-0.43%)